サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1322230

顔用注射剤市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年から2031年

Facial Injectables Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
顔用注射剤市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年から2031年
出版日: 2023年06月28日
発行: Transparency Market Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

顔用注射剤市場- レポートの範囲

世界の顔用注射剤市場に関するTMRのレポートは、過去と現在の成長動向、および2023年から2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。このレポートは、2023年を基準年、2031年を予測年とし、2017年から2031年までの世界市場の収益を提供します。また、2023年から2031年までの世界市場の複合年間成長率（CAGR %）も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、顔用注射剤市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

このレポートは、世界の顔用注射剤市場の競合情勢を掘り下げています。世界の顔用注射剤市場で活動している主要プレーヤーが特定され、これらのそれぞれがさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界の顔用注射剤市場のプレーヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界市場の分析と予測、2017～2031年
  • ポーターのファイブフォース分析

第5章 重要な洞察

  • 技術の進歩
  • 価格分析
  • 主な合併と買収
  • 市場分野で活動する主要3社
  • COVID-19感染症パンデミックによる業界への影響（バリューチェーンと短期・中期・長期的な影響）

第6章 世界市場の分析と予測：製品タイプ別

  • イントロダクションと定義
  • 主な発見/開発
  • 市場金額予測：製品タイプ別、2017-2031
    • コラーゲン
    • ヒアルロン酸（HA）
    • A型ボツリヌス毒素
    • カルシウムヒドロキシルアパタイト（CaHA）
    • ポリメチルメタクリレートビーズ（PMMAマイクロスフェア）
    • ポリ-L-乳酸（PLLA）
    • その他（ポリアルキルイミド）
  • 市場魅力度分析：製品タイプ別

第7章 世界市場の分析と予測：用途別

  • イントロダクションと定義
  • 主な発見/開発
  • 市場金額予測：用途別、2017-2031
    • フェイスライン補正
    • 口唇拡大術
    • ニキビ跡の治療
    • フェイスリフト
    • 脂肪萎縮症の治療
    • その他（耳たぶの若返り）
  • 市場魅力分析：用途別

第8章 世界市場の分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な発見/開発
  • 市場金額予測：エンドユーザー別、2017-2031
    • 病院
    • 皮膚科クリニック
    • その他（美容クリニック）
  • 市場魅力度分析：エンドユーザー別

第9章 世界市場の分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別、2017-2031
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力度分析：地域別

第10章 北米市場の分析と予測

第11章 欧州市場の分析と予測

第12章 アジア太平洋市場の分析と予測

第13章 ラテンアメリカ市場の分析と予測

第14章 中東およびアフリカ市場の分析と予測

第15章 競合情勢

  • 市場プレーヤー-競合マトリックス（企業の階層および規模別）
  • 市場シェア分析：企業別（2021年）
  • 企業プロファイル
    • Allergan, Inc.
    • Ipsen（Mayroy SA）
    • Merz Pharma
    • Suneva Medical, Inc.
    • Medytox Inc.
    • Sinclair Pharma
    • Bloomage BioTechnology
    • Anika Therapeutics, Inc.
    • Prollenium Medical Technologies
    • Galderma
図表

List of Tables

  • Table 01: Global Facial Injectables Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 02: Global Facial Injectables Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 03: Global Facial Injectables Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global Facial Injectables Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Facial Injectables Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Facial Injectables Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 07: North America Facial Injectables Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 08: North America Facial Injectables Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Facial Injectables Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Facial Injectables Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 11: Europe Facial Injectables Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 12: Europe Facial Injectables Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Asia Pacific Facial Injectables Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific Facial Injectables Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 15: Asia Pacific Facial Injectables Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 16: Asia Pacific Facial Injectables Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17: Latin America Facial Injectables Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Facial Injectables Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 19: Latin America Facial Injectables Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 20: Latin America Facial Injectables Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Middle East & Africa Facial Injectables Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Facial Injectables Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 23: Middle East & Africa Facial Injectables Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 24: Middle East & Africa Facial Injectables Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Facial Injectables Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Facial Injectables Market Value Share, by Product Type, 2022
  • Figure 03: Global Facial Injectables Market Value Share, by Application, 2022
  • Figure 04: Global Facial Injectables Market Value Share, by End-user, 2022
  • Figure 05: Global Facial Injectables Market Value Share, by Region, 2022
  • Figure 06: Global Facial Injectables Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 07: Global Facial Injectables Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 08: Global Facial Injectables Market Revenue (US$ Mn), by Collagen, 2017-2031
  • Figure 09: Global Facial Injectables Market Revenue (US$ Mn), by Hyaluronic Acid (HA), 2017-2031
  • Figure 10: Global Facial Injectables Market Revenue (US$ Mn), by Botulinum Toxin Type A, 2017-2031
  • Figure 11: Global Facial Injectables Market Revenue (US$ Mn), by Calcium Hydroxylapatite (CaHA), 2017-2031
  • Figure 12: Global Facial Injectables Market Revenue (US$ Mn), by Polymethylmethacrylate Beads (PMMA Microspheres), 2017-2031
  • Figure 13: Global Facial Injectables Market Revenue (US$ Mn), by Poly-L-Lactic Acid (PLLA), 2017-2031
  • Figure 14: Global Facial Injectables Market Revenue (US$ Mn), by Others (Polyalkylimide), 2017-2031
  • Figure 15: Global Facial Injectables Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 16: Global Facial Injectables Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 17: Global Facial Injectables Market Revenue (US$ Mn), by Facial Line Correction, 2017-2031
  • Figure 18: Global Facial Injectables Market Revenue (US$ Mn), by Lip Augmentation, 2017-2031
  • Figure 19: Global Facial Injectables Market Revenue (US$ Mn), by Acne Scar Treatment, 2017-2031
  • Figure 20: Global Facial Injectables Market Revenue (US$ Mn), by Face Lift, 2017-2031
  • Figure 21: Global Facial Injectables Market Revenue (US$ Mn), by Lipoatrophy Treatment, 2017-2031
  • Figure 22: Global Facial Injectables Market Revenue (US$ Mn), by Others (earlobe rejuvenation), 2017-2031
  • Figure 23: Global Facial Injectables Market Value Share Analysis, by End-user, 2017-2031
  • Figure 24: Global Facial Injectables Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 25: Global Facial Injectables Market Revenue (US$ Mn), by Hospitals, 2017-2031
  • Figure 26: Global Facial Injectables Market Revenue (US$ Mn), by Dermatology Clinics, 2017-2031
  • Figure 27: Global Facial Injectables Market Revenue (US$ Mn), by Others (beauty clinics), 2017-2031
  • Figure 28: Global Facial Injectables Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 29: Global Facial Injectables Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 30: North America Facial Injectables Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 31: North America Facial Injectables Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 32: North America Facial Injectables Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 33: North America Facial Injectables Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 34: North America Facial Injectables Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 35: North America Facial Injectables Market Value Share Analysis (US$ Mn), by Application, 2017-2031
  • Figure 36: North America Facial Injectables Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 37: North America Facial Injectables Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 38: North America Facial Injectables Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 39: Europe Facial Injectables Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 40: Europe Facial Injectables Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 41: Europe Facial Injectables Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 42: Europe Facial Injectables Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 43: Europe Facial Injectables Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 44: Europe Facial Injectables Market Value Share Analysis, by Application, 2017-2031
  • Figure 45: Europe Facial Injectables Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 46: Europe Facial Injectables Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 47: Europe Facial Injectables Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 48: Asia Pacific Facial Injectables Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 49: Asia Pacific Facial Injectables Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 50: Asia Pacific Facial Injectables Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 51: Asia Pacific Facial Injectables Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 52: Asia Pacific Facial Injectables Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 53: Asia Pacific Facial Injectables Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 54: Asia Pacific Facial Injectables Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 55: Asia Pacific Facial Injectables Market Value Share Analysis, by End-user, 2017-2031
  • Figure 56: Asia Pacific Facial Injectables Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 57: Latin America Facial Injectables Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 58: Latin America Facial Injectables Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 59: Latin America Facial Injectables Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 60: Latin America Facial Injectables Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 61: Latin America Facial Injectables Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 62: Latin America Facial Injectables Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 63: Latin America Facial Injectables Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 64: Latin America Facial Injectables Market Value Share Analysis, by End-user, 2017-2031
  • Figure 65: Latin America Facial Injectables Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 66: Middle East & Africa Facial Injectables Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 67: Middle East & Africa Facial Injectables Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 68: Middle East & Africa Facial Injectables Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 69: Middle East & Africa Facial Injectables Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 70: Middle East & Africa Facial Injectables Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 71: Middle East & Africa Facial Injectables Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 72: Middle East & Africa Facial Injectables Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 73: Middle East & Africa Facial Injectables Market Value Share Analysis, by End-user, 2017-2031
  • Figure 74: Middle East & Africa Facial Injectables Market Attractiveness Analysis, by End-user, 2023-2031
目次
Product Code: TMRGL1779

Facial Injectables Market - Scope of Report

TMR's report on the global Facial Injectables Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Facial Injectables Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Facial Injectables Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Facial Injectables Market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Facial Injectables Market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Facial Injectables Market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Facial Injectables Market.

The report delves into the competitive landscape of the global Facial Injectables Market. Key players operating in the global Facial Injectables Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Facial Injectables Market profiled in this report.

Key Questions Answered in Global Facial Injectables Market Report:

  • What is the sales/revenue generated by mobile photo printer across all regions during the forecast period?
  • What are the opportunities in the global Facial Injectables Market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Facial Injectables Market - Research Objectives and Research Approach

The comprehensive report on the global Facial Injectables Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Facial Injectables Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Facial Injectables.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Facial Injectables Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Facial Injectables Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)
    • 4.4.2. Market Volume/Unit Shipments Projections
  • 4.5. Porter's Five Forces Analysis

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. Pricing Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. Top 3 Players Operating in the Market Space
  • 5.5. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

6. Global Facial Injectables Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product Type, 2017-2031
    • 6.3.1. Collagen
    • 6.3.2. Hyaluronic Acid (HA)
    • 6.3.3. Botulinum Toxin Type A
    • 6.3.4. Calcium Hydroxylapatite (CaHA)
    • 6.3.5. Polymethylmethacrylate Beads (PMMA Microspheres)
    • 6.3.6. Poly-L-Lactic Acid (PLLA)
    • 6.3.7. Others (Polyalkylimide )
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Facial Injectables Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Application, 2017-2031
    • 7.3.1. Facial Line Correction
    • 7.3.2. Lip Augmentation
    • 7.3.3. Acne Scar Treatment
    • 7.3.4. Face Lift
    • 7.3.5. Lipoatrophy Treatment
    • 7.3.6. Others (earlobe rejuvenation)
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Facial Injectables Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Hospitals
    • 8.3.2. Dermatology Clinics
    • 8.3.3. Others (beauty clinics)
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Facial Injectables Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2017-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Facial Injectables Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product Type, 2017-2031
    • 10.2.1. Collagen
    • 10.2.2. Hyaluronic Acid (HA)
    • 10.2.3. Botulinum Toxin Type A
    • 10.2.4. Calcium Hydroxylapatite (CaHA)
    • 10.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)
    • 10.2.6. Poly-L-Lactic Acid (PLLA)
    • 10.2.7. Others (Polyalkylimide)
  • 10.3. Market Value Forecast, by Application, 2017-2031
    • 10.3.1. Facial Line Correction
    • 10.3.2. Lip Augmentation
    • 10.3.3. Acne Scar Treatment
    • 10.3.4. Face Lift
    • 10.3.5. Lipoatrophy Treatment
    • 10.3.6. Others (earlobe rejuvenation)
  • 10.4. Market Value Forecast, by End-user, 2017-2031
    • 10.4.1. Hospitals
    • 10.4.2. Dermatology Clinics
    • 10.4.3. Others (Beauty Clinics)
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product Type
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Facial Injectables Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2017-2031
    • 11.2.1. Collagen
    • 11.2.2. Hyaluronic Acid (HA)
    • 11.2.3. Botulinum Toxin Type A
    • 11.2.4. Calcium Hydroxylapatite (CaHA)
    • 11.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)
    • 11.2.6. Poly-L-Lactic Acid (PLLA)
    • 11.2.7. Others (Polyalkylimide)
  • 11.3. Market Value Forecast, by Application, 2017-2031
    • 11.3.1. Facial Line Correction
    • 11.3.2. Lip Augmentation
    • 11.3.3. Acne Scar Treatment
    • 11.3.4. Face Lift
    • 11.3.5. Lipoatrophy Treatment
    • 11.3.6. Others (earlobe rejuvenation)
  • 11.4. Market Value Forecast, by End-user, 2017-2031
    • 11.4.1. Hospitals
    • 11.4.2. Dermatology Clinics
    • 11.4.3. Others (beauty clinics)
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product Type
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Facial Injectables Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2017-2031
    • 12.2.1. Collagen
    • 12.2.2. Hyaluronic Acid (HA)
    • 12.2.3. Botulinum Toxin Type A
    • 12.2.4. Calcium Hydroxylapatite (CaHA)
    • 12.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)
    • 12.2.6. Poly-L-Lactic Acid (PLLA)
    • 12.2.7. Others (Polyalkylimide)
  • 12.3. Market Value Forecast, by Application, 2017-2031
    • 12.3.1. Facial Line Correction
    • 12.3.2. Lip Augmentation
    • 12.3.3. Acne Scar Treatment
    • 12.3.4. Face Lift
    • 12.3.5. Lipoatrophy Treatment
    • 12.3.6. Others (earlobe rejuvenation)
  • 12.4. Market Value Forecast, by End-user, 2017-2031
    • 12.4.1. Hospitals
    • 12.4.2. Dermatology Clinics
    • 12.4.3. Others (beauty clinics)
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Facial Injectables Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2017-2031
    • 13.2.1. Collagen
    • 13.2.2. Hyaluronic Acid (HA)
    • 13.2.3. Botulinum Toxin Type A
    • 13.2.4. Calcium Hydroxylapatite (CaHA)
    • 13.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)
    • 13.2.6. Poly-L-Lactic Acid (PLLA)
    • 13.2.7. Others (Polyalkylimide)
  • 13.3. Market Value Forecast, by Application, 2017-2031
    • 13.3.1. Facial Line Correction
    • 13.3.2. Lip Augmentation
    • 13.3.3. Acne Scar Treatment
    • 13.3.4. Face Lift
    • 13.3.5. Lipoatrophy Treatment
    • 13.3.6. Others (earlobe rejuvenation)
  • 13.4. Market Value Forecast, by End-user, 2017-2031
    • 13.4.1. Hospitals
    • 13.4.2. Dermatology Clinics
    • 13.4.3. Others (beauty clinics)
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product Type
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Facial Injectables Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2017-2031
    • 14.2.1. Collagen
    • 14.2.2. Hyaluronic Acid (HA)
    • 14.2.3. Botulinum Toxin Type A
    • 14.2.4. Calcium Hydroxylapatite (CaHA)
    • 14.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)
    • 14.2.6. Poly-L-Lactic Acid (PLLA)
    • 14.2.7. Others (Polyalkylimide)
  • 14.3. Market Value Forecast, by Application, 2017-2031
    • 14.3.1. Facial Line Correction
    • 14.3.2. Lip Augmentation
    • 14.3.3. Acne Scar Treatment
    • 14.3.4. Face Lift
    • 14.3.5. Lipoatrophy Treatment
    • 14.3.6. Others (earlobe rejuvenation)
  • 14.4. Market Value Forecast, by End-user, 2017-2031
    • 14.4.1. Hospitals
    • 14.4.2. Dermatology Clinics
    • 14.4.3. Others (beauty clinics)
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product Type
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company (2021)
  • 15.3. Company Profiles
    • 15.3.1. Allergan, Inc.
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Ipsen (Mayroy SA)
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Merz Pharma
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Suneva Medical, Inc.
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Medytox Inc.
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Sinclair Pharma
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Bloomage BioTechnology
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Anika Therapeutics, Inc.
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Prollenium Medical Technologies
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
    • 15.3.10. Galderma
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. SWOT Analysis
      • 15.3.10.5. Strategic Overview